StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.48−0.12 (-7.50%)

Close on Nov 17, 2026Market cap $87.66MP/E –Yield –

Adagene price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Adagene's price to sales ratio was 23.3× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 4.8× to 425.2×, with a median of 10.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202623.3×+16.8
2025Feb 28, 20256.5×+0.5
2024Dec 31, 20246.1×−5.2
2023Dec 29, 202311.2×+4.1
2022Dec 30, 20227.1×−184.0
2021Dec 31, 2021191.1×–

More Adagene figures

See a number that looks wrong?